Previous close | 220.78 |
Open | 219.56 |
Bid | 218.25 x 800 |
Ask | 218.40 x 900 |
Day's range | 218.23 - 219.45 |
52-week range | 156.72 - 231.86 |
Volume | |
Avg. volume | 1,254,322 |
Market cap | 62.46B |
Beta (5Y monthly) | 1.10 |
PE ratio (TTM) | 45.61 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 2.28 (1.03%) |
Ex-dividend date | 18 Mar 2024 |
1y target est | N/A |
Besides Wall Street's top -and-bottom-line estimates for Ecolab (ECL), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2024.
Penumbra's (PEN) latest offering is likely to enable physicians to restore blood flow more quickly and further minimize blood loss.
Ingevity (NGVT) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.